1.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: 2005-004933-16, NCT00281476
|
|
2.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Prevention Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: JHOC-J0485, CDR0000477214, P50CA088843, P30CA006973, JHOC-J0485, JHOC-SKCCC-J0485, JHOC-04100404, J0485, NCT00334542
|
|
3.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: SMC IRB 2005-08-011, NCT00313859
|
|
4.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Prevention, Treatment Status: Closed Age: Postmenopausal Sponsor: NCI, Other Protocol IDs: J05100, CDR0000485361, P30CA006973, JHOC-J05100, JHOC-SKCCC-J05100, J05100, NCT00354640
|
|
5.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: NCCCTS-06-177, NCT00452244
|
|
6.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: NCCCTS-06-176, NCT00452634
|
|
7.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: 07-175, NCT00575965
|
|
8.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: SMC IRB 2010-08-006, NCT01281761
|
|
9.
|
Phase: No phase specified Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: 08-LEUK-06-MCC, NCT00828282
|